Cargando…
Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening
BACKGROUND: SARS-CoV-2 test kits are in critical shortage in many countries. This limits large-scale population testing and hinders the effort to identify and isolate infected individuals. OBJECTIVE: Herein, we developed and evaluated multi-stage group testing schemes that test samples in groups of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177109/ https://www.ncbi.nlm.nih.gov/pubmed/32388468 http://dx.doi.org/10.1016/j.jcv.2020.104382 |
_version_ | 1783525148311158784 |
---|---|
author | Eberhardt, J.N. Breuckmann, N.P. Eberhardt, C.S. |
author_facet | Eberhardt, J.N. Breuckmann, N.P. Eberhardt, C.S. |
author_sort | Eberhardt, J.N. |
collection | PubMed |
description | BACKGROUND: SARS-CoV-2 test kits are in critical shortage in many countries. This limits large-scale population testing and hinders the effort to identify and isolate infected individuals. OBJECTIVE: Herein, we developed and evaluated multi-stage group testing schemes that test samples in groups of various pool sizes in multiple stages. Through this approach, groups of negative samples can be eliminated with a single test, avoiding the need for individual testing and achieving considerable savings of resources. STUDY DESIGN: We designed and parameterized various multi-stage testing schemes and compared their efficiency at different prevalence rates using computer simulations. RESULTS: We found that three-stage testing schemes with pool sizes of maximum 16 samples can test up to three and seven times as many individuals with the same number of test kits for prevalence rates of around 5% and 1%, respectively. We propose an adaptive approach, where the optimal testing scheme is selected based on the expected prevalence rate. CONCLUSION: These group testing schemes could lead to a major reduction in the number of testing kits required and help improve large-scale population testing in general and in the context of the current COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-7177109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71771092020-04-23 Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening Eberhardt, J.N. Breuckmann, N.P. Eberhardt, C.S. J Clin Virol Article BACKGROUND: SARS-CoV-2 test kits are in critical shortage in many countries. This limits large-scale population testing and hinders the effort to identify and isolate infected individuals. OBJECTIVE: Herein, we developed and evaluated multi-stage group testing schemes that test samples in groups of various pool sizes in multiple stages. Through this approach, groups of negative samples can be eliminated with a single test, avoiding the need for individual testing and achieving considerable savings of resources. STUDY DESIGN: We designed and parameterized various multi-stage testing schemes and compared their efficiency at different prevalence rates using computer simulations. RESULTS: We found that three-stage testing schemes with pool sizes of maximum 16 samples can test up to three and seven times as many individuals with the same number of test kits for prevalence rates of around 5% and 1%, respectively. We propose an adaptive approach, where the optimal testing scheme is selected based on the expected prevalence rate. CONCLUSION: These group testing schemes could lead to a major reduction in the number of testing kits required and help improve large-scale population testing in general and in the context of the current COVID-19 pandemic. Elsevier B.V. 2020-07 2020-04-23 /pmc/articles/PMC7177109/ /pubmed/32388468 http://dx.doi.org/10.1016/j.jcv.2020.104382 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Eberhardt, J.N. Breuckmann, N.P. Eberhardt, C.S. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |
title | Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |
title_full | Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |
title_fullStr | Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |
title_full_unstemmed | Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |
title_short | Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening |
title_sort | multi-stage group testing improves efficiency of large-scale covid-19 screening |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177109/ https://www.ncbi.nlm.nih.gov/pubmed/32388468 http://dx.doi.org/10.1016/j.jcv.2020.104382 |
work_keys_str_mv | AT eberhardtjn multistagegrouptestingimprovesefficiencyoflargescalecovid19screening AT breuckmannnp multistagegrouptestingimprovesefficiencyoflargescalecovid19screening AT eberhardtcs multistagegrouptestingimprovesefficiencyoflargescalecovid19screening |